Skip to headlines

BUSINESS

Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

CNBC BusinessMonday, September 21, 2026 at 7:37 PM

RedScroll Brief

They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.

RedScroll Signal

Impact
High
Category
Business
Market relevance
High
Why it matters
Corporate and market moves reprice risk and reveal where power and cash are concentrating. They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July. Investors will watch earnings, rates, and competitive positioning connected to Eli Lilly and Medicare.

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.

Why it matters

Corporate and market moves reprice risk and reveal where power and cash are concentrating.

Background

CNBC Business reported on this under business. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

  1. CNBC Business published: Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

  2. Story is in today’s RedScroll edition. Follow the original source for updates.

Economic impact

Investors will watch earnings, rates, and competitive positioning connected to Eli Lilly and Medicare.

More on

Related stories

Source

CNBC Business

Original reporting by CNBC Business. RedScroll provides an extractive briefing only.